MiniMed (MMED) EBITDA Margin (2025 - 2026)
MiniMed's (MMED) quarterly EBITDA Margin came in at 11.11% in Q2 2026, up 933.0% YoY from 1.08% in Q2 2025, and up 12.22% on a QoQ basis from 12.66% in Q1 2026.
Powered by 
Analysis
MiniMed (MMED) EBITDA Margin (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of EBITDA Margin data on file, last reported at 11.11% in Q2 2026.
- Quarterly EBITDA Margin rose 933.0% year-over-year to 11.11% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 10.53% (changed N/A YoY) and the FY2026 annual result came in at 6.13%, down 75.0% from the prior year.
- EBITDA Margin grew to 11.11% in Q2 2026, from 12.66% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 3.06% in Q1 2025 to a low of 20.44% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 46.14 Bn | 38.90 Bn | 695.95 Mn | 29.64% |
| 2 | BrightSpring Health Services | 12.64 Bn | 12.07 Bn | 492.75 Mn | 3.37% |
| 3 | Tempus AI | 11.63 Bn | 10.82 Bn | 274.25 Mn | -19.85% |
| 4 | Healthequity | 8.23 Bn | 7.98 Bn | 257.95 Mn | 28.14% |
| 5 | 10x Genomics | 8.23 Bn | 7.68 Bn | 112.50 Mn | -12.95% |
| 6 | Hinge Health | 7.20 Bn | 6.81 Bn | 183.95 Mn | 19.00% |
| 7 | MiniMed | 6.10 Bn | 5.81 Bn | 480.00 Mn | -11.11% |
| 8 | Waystar Holding | 4.99 Bn | 4.80 Bn | 221.99 Mn | 25.98% |
| 9 | Doximity | 4.92 Bn | 4.23 Bn | 132.93 Mn | 21.48% |
| 10 | Heartflow | 4.30 Bn | 3.92 Bn | 53.19 Mn | -27.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 24, 2026 | -11.11% |
| Jan 23, 2026 | -12.66% |
| Apr 25, 2025 | -20.44% |
| Jan 24, 2025 | 3.06% |